Is There Need for a New Hepatitis B Vaccine Schedule for Children with Celiac Disease?

Basit Öğe Kaydı
dc.contributor.authorErtekin, Vildan
dc.contributor.authorTosun, Mahya Sultan
dc.contributor.authorSelimoglu, Mukadder Ayse
dc.date.accessioned2024-08-04T20:59:47Z
dc.date.available2024-08-04T20:59:47Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Celiac disease (CD) is an autoimmune disease characterized by immune-mediated inflammatory damage of the small intestinal mucosa, precipitated by the ingestion of gluten-containing foods. Since human leucocyte antigen DQ2 (HLA-DQ2) is a marker of nonresponsiveness to hepatits B virus (HBV) vaccine, CD may also be associated with this nonresponsiveness. Objectives: The aim of this study was to compare the responses to HBV vaccine between children with CD and healthy children. we also investigated the relationship between the patients' responses to hepatitis B vaccine, the clinical presentation of CD, and dietary compliance in the patients. Patients and Methods: We recruited 52 children with CD and 20 age- and sex-matched healthy children who received HBV vaccination according to the standard immunization schedule. The production of specific antihepatitis B surface antigen (HBsAg) antibodies was evaluated in all patients and control participants. Subjects with less than 10 IU/L anti-HBs were considered nonresponders to the vaccination. Results: 31 of the 52 patients (59.6%) were female and 21 (40.4%) were male. The mean age of the CD patients was 10.7 +/- 4 years (range, 4-18 years). Anti-HBs titers were positive in 32(61.5%) patients and negative in 20 (38.5%) patients, while they were positive in 18 (90%) of the children in the control group (P < 0.05). We found statistically significant differences between negative anti-HBs titers, clinical presentation of CD, and dietary compliance in patients with CD (P < 0.05). Conclusions: Nonresponsiveness to hepatitis B vaccination was more frequently found in children with CD than in the control group. Therefore, the response to HBV vaccination should be investigated in children with CD, and a different immunization schedule may need to be developed. Further, compliance to the prescribed gluten-free diet (GFD) may improve the immune response to HBV vaccination in children with CD. (C) 2011 Kowsar M.P.Co. All rights reserved.en_US
dc.identifier.doi10.5812/kowsar.1735143X.715
dc.identifier.endpage637en_US
dc.identifier.issn1735-143X
dc.identifier.issue8en_US
dc.identifier.pmid22140387en_US
dc.identifier.startpage634en_US
dc.identifier.urihttps://doi.org/10.5812/kowsar.1735143X.715
dc.identifier.urihttps://hdl.handle.net/11616/103532
dc.identifier.volume11en_US
dc.identifier.wosWOS:000295353100007en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBaqiyatallah Research Centeren_US
dc.relation.ispartofHepatitis Monthlyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCeliac diseaseen_US
dc.subjectHepatitis B vaccineen_US
dc.subjectChilden_US
dc.titleIs There Need for a New Hepatitis B Vaccine Schedule for Children with Celiac Disease?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu